{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:17:27Z","timestamp":1790907447576,"version":"4.1.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["503\/0-078-02\/ 503-01-003-18"],"award-info":[{"award-number":["503\/0-078-02\/ 503-01-003-18"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00345","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T03:24:43Z","timestamp":1535426683000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions"],"prefix":"10.3389","volume":"8","author":[{"given":"Karolina","family":"Pospiech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"P\u0142uciennik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej K.","family":"Bednarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"B1","first-page":"2140","article-title":"WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer","volume":"60","author":"Bednarek","year":"2000","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8751","DOI":"10.1073\/pnas.87.22.8751","article-title":"Allelic loss of chromosomes 16q and 10q in human prostate cancer","volume":"87","author":"Carter","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/gcc.20932","article-title":"Copy number alterations in prostate tumors and disease aggressiveness","volume":"51","author":"Cheng","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ijc.2910510605","article-title":"Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma","volume":"51","author":"Nishida","year":"1992","journal-title":"Int J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jhep.2008.05.015","article-title":"The JNK inhibitor SP60(0129)enhances apoptosis of HCC cells induced by the tumor suppressor WWOX","volume":"49","author":"Aderca","year":"2008","journal-title":"J Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1158\/1078-0432.CCR-03-0594","article-title":"Loss of WWOX expression in gastric carcinoma","volume":"10","author":"Aqeilan","year":"2004","journal-title":"Clin Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1038\/sj.onc.1204674","article-title":"Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma","volume":"20","author":"Yakicier","year":"2001","journal-title":"Oncogene"},{"key":"B8","first-page":"6172","article-title":"Genetic analysis of benign, low-grade, and high-grade ovarian tumors","volume":"55","author":"Iwabuchi","year":"1995","journal-title":"Cancer Res"},{"key":"B9","first-page":"5605","article-title":"Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region","volume":"56","author":"Chen","year":"1996","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/geno.1998.5316","article-title":"Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer","volume":"50","author":"Whitmore","year":"1998","journal-title":"Genomics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00432-008-0449-4","article-title":"Loss of WWOX expression in human extrahepatic cholangiocarcinoma","volume":"135","author":"Wang","year":"2009","journal-title":"J Cancer Res Clin Oncol."},{"key":"B12","first-page":"2258","article-title":"Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma","volume":"62","author":"Kuroki","year":"2002","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1158\/0008-5472.CAN-07-6710","article-title":"Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays","volume":"68","author":"Nancarrow","year":"2008","journal-title":"Cancer Res."},{"key":"B14","first-page":"878","article-title":"WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer","volume":"63","author":"Yendamuri","year":"2003","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/j.1349-7006.2008.00841.x","article-title":"Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells","volume":"99","author":"Nakayama","year":"2008","journal-title":"Cancer Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-03-0096","article-title":"The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis","volume":"10","author":"Kuroki","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1182\/blood-2007-02-075069","article-title":"Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma","volume":"110","author":"Jenner","year":"2007","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/gcc.20305","article-title":"Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer","volume":"45","author":"Sbrana","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11060-010-0254-1","article-title":"Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme","volume":"101","author":"Kosla","year":"2011","journal-title":"J Neurooncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/ejso.1999.0742","article-title":"16q heterozygosity loss in Wilms' tumour in children and its clinical importance","volume":"26","author":"Skotnicka-Klonowicz","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/1078-0432.CCR-06-2016","article-title":"WWOX expression in different histologic types and subtypes of non-small cell lung cancer","volume":"13","author":"Donati","year":"2007","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1245\/s10434-009-0507-4","article-title":"Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features","volume":"16","author":"Bloomston","year":"2009","journal-title":"Ann Surg Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1038\/sj.onc.1207474","article-title":"Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer","volume":"23","author":"Watson","year":"2004","journal-title":"Oncogene"},{"key":"B24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2407-5-64","article-title":"WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome","volume":"5","author":"Nunez","year":"2005","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1089\/thy.2007.0232","article-title":"Association between decreased WWOX protein expression and thyroid cancer development","volume":"17","author":"Dias","year":"2007","journal-title":"Thyroid Off J Am Thyroid Assoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2559.2008.03033.x","article-title":"Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours","volume":"52","author":"Ramos","year":"2008","journal-title":"Histopathology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10735-006-9046-5","article-title":"WWOX protein expression in normal human tissues","volume":"37","author":"Nunez","year":"2006","journal-title":"J Mol Histol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1158\/0008-5472.CAN-11-3142","article-title":"Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer","volume":"72","author":"Asmann","year":"2012","journal-title":"Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature14475","article-title":"Genome-wide identification of zero nucleotide recursive splicing in Drosophila","volume":"521","author":"Duff","year":"2015","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B31","first-page":"8068","article-title":"WWOX, the FRA16D gene, behaves as a suppressor of tumor growth","volume":"61","author":"Bednarek","year":"2001","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/sj.onc.1205273","article-title":"Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors","volume":"21","author":"Driouch","year":"2002","journal-title":"Oncogene"},{"key":"B33","first-page":"8629","article-title":"An opposing view on WWOX protein function as a tumor suppressor","volume":"63","author":"Watanabe","year":"2003","journal-title":"Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"11417","DOI":"10.1073\/pnas.191175898","article-title":"WWOX: a candidate tumor suppressor gene involved in multiple tumor types","volume":"98","author":"Paige","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jmb.2012.05.015","article-title":"Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors","volume":"422","author":"McDonald","year":"2012","journal-title":"J Mol Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jmr.2419","article-title":"Allostery mediates ligand binding to WWOX tumor suppressor via a conformational switch","volume":"28","author":"Schuchardt","year":"2015","journal-title":"J Mol Recognit."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8865","DOI":"10.1074\/jbc.M113.506790","article-title":"Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks","volume":"289","author":"Abu-Odeh","year":"2014","journal-title":"J Biol Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"9223","DOI":"10.1021\/bi400987k","article-title":"Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase","volume":"52","author":"Schuchardt","year":"2013","journal-title":"Biochemistry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2217\/fon.09.152","article-title":"WWOX gene and gene product: tumor suppression through specific protein interactions","volume":"6","author":"Salah","year":"2010","journal-title":"Future Oncol Lond Engl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-04-2055","article-title":"Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor","volume":"64","author":"Aqeilan","year":"2004","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"11585","DOI":"10.1158\/0008-5472.CAN-06-3376","article-title":"Physical association with WWOX suppresses c-Jun transcriptional activity","volume":"66","author":"Gaudio","year":"2006","journal-title":"Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/onc.2009.120","article-title":"Inhibition of the Wnt\/beta-catenin pathway by the WWOX tumor suppressor protein","volume":"28","author":"Bouteille","year":"2009","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"21629","DOI":"10.1074\/jbc.M800855200","article-title":"The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism","volume":"283","author":"Aqeilan","year":"2008","journal-title":"J Biol Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/1471-2407-13-593","article-title":"The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding","volume":"13","author":"Ferguson","year":"2013","journal-title":"BMC Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.bbrc.2013.12.133","article-title":"Wwox suppresses breast cancer cell growth through modulation of the hedgehog-GLI1 signaling pathway","volume":"443","author":"Xiong","year":"2014","journal-title":"Biochem Biophys Res Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1158\/0008-5472.CAN-05-1150","article-title":"WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function","volume":"65","author":"Aqeilan","year":"2005","journal-title":"Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.bbrc.2006.01.023","article-title":"PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction","volume":"341","author":"Jin","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10585-006-9050-x","article-title":"Expression of the cytoskeleton linker protein ezrin in human cancers","volume":"24","author":"Bruce","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"43100","DOI":"10.1074\/jbc.M505590200","article-title":"WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53","volume":"280","author":"Chang","year":"2005","journal-title":"J Biol Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1021\/bi00018a001","article-title":"Short-chain dehydrogenases\/reductases (SDR)","volume":"34","author":"J\u00f6rnvall","year":"1995","journal-title":"Biochemistry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1046\/j.1432-1033.2002.03130.x","article-title":"Short-chain dehydrogenases\/reductases (SDRs)","volume":"269","author":"Kallberg","year":"2002","journal-title":"Eur J Biochem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0039-128X(96)00166-3","article-title":"Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer","volume":"62","author":"Duax","year":"1997","journal-title":"Steroids"},{"key":"B53","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1110\/ps.26902","article-title":"Short-chain dehydrogenase\/reductase (SDR) relationships: a large family with eight clusters common to human, animal, and plant genomes","volume":"11","author":"Kallberg","year":"2002","journal-title":"Protein Sci Publ Protein Soc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/me.2002-0436","article-title":"Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis","volume":"17","author":"Marijanovic","year":"2003","journal-title":"Mol Endocrinol Baltim Md."},{"key":"B55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1515\/znc-2011-1-210","article-title":"WWOX oxidoreductase\u2013substrate and enzymatic characterization","volume":"66","author":"Sa\u0142uda-Gorgul","year":"2011","journal-title":"Z Naturforschung C"},{"key":"B56","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/sj.onc.1208124","article-title":"17beta-Estradiol upregulates and activates WOX1\/WWOXv1 and WOX2\/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo","volume":"24","author":"Chang","year":"2005"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1210\/en.2008-1087","article-title":"Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis","volume":"150","author":"Aqeilan","year":"2009","journal-title":"Endocrinology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ajhg.2008.07.002","article-title":"WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels","volume":"83","author":"Lee","year":"2008","journal-title":"Am J Hum Genet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCGENETICS.113.000248","article-title":"The WWOX gene modulates high-density lipoprotein and lipid metabolism","volume":"7","author":"Iatan","year":"2014","journal-title":"Circ Cardiovasc Genet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-010-1248-6","article-title":"Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features","volume":"129","author":"Guler","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B61","doi-asserted-by":"publisher","first-page":"E4716","DOI":"10.1073\/pnas.1409252111","article-title":"WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response","volume":"111","author":"Abu-Odeh","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1007\/s00018-014-1724-y","article-title":"The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability","volume":"71","author":"Aqeilan","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.18632\/oncotarget.6571","article-title":"WWOX modulates the ATR-mediated DNA damage checkpoint response","volume":"7","author":"Abu-Odeh","year":"2016","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/onc.2016.389","article-title":"Wwox-Brca1 interaction: role in DNA repair pathway choice","volume":"36","author":"Schrock","year":"2017","journal-title":"Oncogene"},{"key":"B65","doi-asserted-by":"publisher","first-page":"15611","DOI":"10.1073\/pnas.0505485102","article-title":"WWOX gene restoration prevents lung cancer growth in vitro and in vivo","volume":"102","author":"Fabbri","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1158\/0008-5472.CAN-06-0956","article-title":"A role for the WWOX gene in prostate cancer","volume":"66","author":"Qin","year":"2006","journal-title":"Cancer Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1158\/0008-5472.CAN-08-2974","article-title":"WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3","volume":"69","author":"Gourley","year":"2009","journal-title":"Cancer Res."},{"key":"B68","first-page":"47","article-title":"WWOX, the tumour suppressor gene affected in multiple cancers","volume":"60","author":"Lewandowska","year":"2009","journal-title":"J Physiol Pharmacol. c"},{"key":"B69","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1158\/1078-0432.CCR-06-2038","article-title":"Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression","volume":"13","author":"Iliopoulos","year":"2007","journal-title":"Clin Cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11596-010-0358-z","article-title":"Cloning of WWOX gene and its growth-inhibiting effects on ovarian cancer cells","volume":"30","author":"Xiong","year":"2010","journal-title":"J Huazhong Univ Sci Technol Med Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1038\/onc.2011.115","article-title":"Wwox inactivation enhances mammary tumorigenesis","volume":"30","author":"Abdeen","year":"2011","journal-title":"Oncogene"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036618","article-title":"Conditional Wwox deletion in mouse mammary gland by means of two Cre recombinase approaches","author":"Ferguson","year":"2012","journal-title":"PLoS ONE"},{"key":"B73","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbcan.2014.06.001","article-title":"WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies","volume":"1846","author":"Aldaz","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/sj.onc.1208398","article-title":"Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer","volume":"24","author":"Iliopoulos","year":"2005","journal-title":"Oncogene"},{"key":"B75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000197911","article-title":"Association between CpG island methylation of the WWOX gene and its expression in breast cancers","volume":"30","author":"Wang","year":"2009","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s12032-011-0080-0","article-title":"Genetic alterations of the WWOX gene in breast cancer","volume":"29","author":"Ekizoglu","year":"2012","journal-title":"Med Oncol Northwood Lond Engl."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/hmg\/ddi144","article-title":"Common chromosomal fragile site FRA16D mutation in cancer cells","volume":"14","author":"Finnis","year":"2005","journal-title":"Hum Mol Genet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1158\/0008-5472.CAN-05-1127","article-title":"Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox","volume":"65","author":"Mahajan","year":"2005","journal-title":"Cancer Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2011.03.127","article-title":"Helicobacter pylori infection promotes methylation of WWOX gene in human gastric cancer","volume":"408","author":"Yan","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/sj.bjc.6604986","article-title":"Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas","volume":"100","author":"Nakayama","year":"2009","journal-title":"Br J Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13277-010-0039-3","article-title":"WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC)","volume":"31","author":"Baykara","year":"2010","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B83","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000072844","article-title":"WWOX, the common chromosomal fragile site, FRA16D, cancer gene","volume":"100","author":"Ludes-Meyers","year":"2003","journal-title":"Cytogenet Genome Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/cncr.20137","article-title":"The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma","volume":"100","author":"Guler","year":"2004","journal-title":"Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10549-004-1474-x","article-title":"Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status","volume":"89","author":"Nunez","year":"2005","journal-title":"Breast Cancer Res Treat."},{"key":"B86","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1440-1827.2005.01855.x","article-title":"Concordant loss of fragile gene expression early in breast cancer development","volume":"55","author":"Guler","year":"2005","journal-title":"Pathol Int."},{"key":"B87","first-page":"CR132","article-title":"Breast cancer relapse prediction based on multi-gene RT-PCR algorithm","volume":"16","author":"Pluciennik","year":"2010","journal-title":"Med Sci Monit Int Med J Exp Clin Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejso.2005.11.002","article-title":"WWOX\u2013the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis","volume":"32","author":"P\u0142uciennik","year":"2006","journal-title":"Eur J Surg Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cncr.24103","article-title":"Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer","volume":"115","author":"Guler","year":"2009","journal-title":"Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1158\/1078-0432.CCR-07-1282","article-title":"Wwox and Ap2gamma expression levels predict tamoxifen response","volume":"13","author":"Guler","year":"2007","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3892\/or.2013.2261","article-title":"Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients","volume":"29","author":"G\u00f6thlin Eremo","year":"2013","journal-title":"Oncol Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejca.2012.05.006","article-title":"Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors","volume":"49","author":"Matteucci","year":"2013","journal-title":"Eur J Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.yexcr.2014.10.004","article-title":"Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1\u03b1 stabilization\/nuclear translocation in bone metastasis from breast carcinoma","volume":"330","author":"Maroni","year":"2015","journal-title":"Exp Cell Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-015-0389-y","article-title":"HGF and TGF\u03b21 differently influenced Wwox regulatory function on twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells","volume":"14","author":"Bendinelli","year":"2015","journal-title":"Mol Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ijms18010075","article-title":"Functions and epigenetic regulation of wwox in bone metastasis from breast carcinoma: comparison with primary tumors","volume":"18","author":"Maroni","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/cdd.2014.95","article-title":"Tumor suppressor WWOX regulates glucose metabolism via HIF1\u03b1 modulation","volume":"21","author":"Abu-Remaileh","year":"2014","journal-title":"Cell Death Differ"},{"key":"B97","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B99","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jbior.2016.09.008","article-title":"Fhit and Wwox loss-associated genome instability: a genome caretaker one-two punch","volume":"63","author":"Schrock","year":"2017","journal-title":"Adv Biol Regul."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.403","article-title":"Epigenetic regulation of HGF\/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma","author":"Bendinelli","year":"2017","journal-title":"Cell Death Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.ejca.2013.03.002","article-title":"Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer","volume":"49","author":"Bendinelli","year":"2013","journal-title":"Eur J Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e965640","DOI":"10.4161\/23723548.2014.965640","article-title":"WWOX loss activates aerobic glycolysis","volume":"2","author":"Abu-Remaileh","year":"2015","journal-title":"Mol Cell Oncol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/jcp.24310","article-title":"Characterization of WWOX inactivation in murine mammary gland development","volume":"228","author":"Abdeen","year":"2013","journal-title":"J Cell Physiol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00432-010-0880-","article-title":"The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype","volume":"137","author":"Wang","year":"2011","journal-title":"J Cancer Res Clin Oncol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1158\/0008-5472.CAN-07-2147","article-title":"Association of Wwox with ErbB4 in breast cancer","volume":"67","author":"Aqeilan","year":"2007","journal-title":"Cancer Res."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T03:24:49Z","timestamp":1535426689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":105,"alternative-id":["10.3389\/fonc.2018.00345"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00345","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"article-number":"345"}}